Ketosteril

L‑Lysine acetate, L‑tryptophan, L‑histidine, L‑threonine, L‑tyrosine, keto‑isoleucine calcium and related keto‑analogues, the active ingredients in Ketosteril, are a ketoanalog supplement presented as an oral formulation for renal nutrition support use. It is employed to manage chronic kidney disease and related protein‑restriction needs in patients requiring dietary management.

GNH USA supplies Ketosteril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The product is manufactured in the European Union under strict GMP standards, ensuring consistent quality for renal nutrition therapy.

Ketosteril is used in renal nutrition support to address protein‑restriction and metabolic needs in chronic kidney disease.

Chronic kidney disease: helps reduce nitrogen waste and supports protein metabolism. Renal failure: provides essential amino acid precursors while limiting dietary protein load. Dietary protein restriction in renal patients: supplies keto‑analogues that are converted to essential amino acids, allowing lower protein intake.

Ketosteril may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea. - Vomiting. - Loss of appetite.

Serious or Rare Side Effects: - Hyperkalemia. - Severe allergic reactions such as rash or angioedema. - Metabolic acidosis.

When prescribing Ketosteril, clinicians should observe several precautionary measures to ensure patient safety.

Monitor renal function: regular assessment of serum creatinine and urea. Adjust dose in severe renal impairment: dose may need reduction. Avoid in known hypersensitivity: discontinue if allergic signs appear. Caution with potassium‑rich diets: risk of hyperkalemia. Use under medical supervision: only for patients with prescribed protein restriction. Store at below 25°C: keep in original container, protect from moisture.

Ketosteril can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - High‑protein nutritional supplements: may negate the nitrogen‑sparing effect. - Potassium‑sparing diuretics: increase risk of hyperkalemia. - ACE inhibitors or ARBs: may exacerbate potassium elevation.

Moderate Interactions (Monitor Closely): - Phosphate binders: may affect keto‑analogue absorption. - Antacids: can alter gastric pH and conversion efficiency. - Loop diuretics: require monitoring of electrolyte balance.